Hamed Abbaszadegan, MD, MBA, will lead the Clinical Informatics Fellowship with Plans to Revolutionize Health Care Through Information TechnologyContinue reading
Author Archive: AZBio
SinfoníaRx Acquired by Tabula Rasa HealthCare Inc
Spun out as a UA startup company in 2013, SinfoníaRx pioneered modern medication therapy management services and has now been purchased by Tabula Rasa HealthCare Inc.Continue reading
ASU a key player in Arizona Wellbeing Commons, an umbrella group that aims to tackle complex disease issues
Arizona State University is a key player in a new health research initiative designed to harness the expertise of scientists across the state to treat diseases like cancer and address such problems as unequal access to health care.Continue reading
Midwestern University researchers discover previously unknown cause of nTOS
Findings also show efficacy of ultrasound diagnostics in revealing brachial plexus piercing variations in subjects with nTOS symptoms
TGen launchs new high school science program
The Translational Genomics Research Institute (TGen) and Helios Education Foundation today announced the formation of a new biomedical studies program designed specifically for high school students to elevate their understanding of bioscience and precision medicine. (Republished with permission. Posted September 5, 2017 by
UA Team Tackles Better Brain Health
A trial will look at whether a naturally occurring compound, known as angiotensin 1-7, relieves cognitive deficits after heart bypass. The UA collaborators include a cardiologist, a physiologist and a psychologist.
Avery Therapeutics Inc. to be honored with an AZBio Fast Lane Award
The Arizona Bioindustry Association will honor Avery Therapeutics Inc. with an AZBio Fast Lane Award at the 2017 AZBio Awards. Arizona life science and business leaders as well as guests from across the country will be on hand to applaud the Avery Therapeutics team for their progress in developing a novel lifesaving medical device to address heart failure.Continue reading
UA-Invented Sunscreen Licensed to Leading World Aloevera Supplier
Tucson, Ariz. – The University of Arizona has licensed a new non-penetrating sunscreen to MexiAloe Laboratorios, S.A. de C.V., a subsidiary of Novamex.Continue reading
Calimmune to be purchased by CSL Behring
CSL Behring, has entered into a deal to buy Calimmune Inc. for $91 million. The deal also includes the potential for Calimmune to earn additional performance based milestone payments of up to $325 million over a period currently anticipated to be around eight years or more following the closing of the transaction. The transaction is expected to close within the next two weeks.Continue reading